The average lifespan of patients discharged from hospital with heart failure

Journal of General Internal Medicine

Volumn 27, Issue 9, 2012, Pages 1171-1179

  Alter, David A ^a,b,d,e   Ko, Dennis T ^a,b   Tu, Jack V ^a,b   Stukel, Therese A ^a,b   Lee, Douglas S ^a,b,c   Laupacis, Andreas ^a,b,e   Chong, Alice ^a   Austin, Peter C ^a,b  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d TORONTO REHABILITATION INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Comorbidity; Heart failure; Life expectancy; Risk; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CARDIAC PATIENT; COHORT ANALYSIS; COMORBIDITY; FEMALE; GENDER; GROUPS BY AGE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; LIFE EXPECTANCY; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HEART FAILURE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PATIENT DISCHARGE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84866927607     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2072-y     Document Type: Article

References (56)

1. Heron M, Tejada-Vera B. Deaths: leading causes for 2005. Natl Vital Stat Rep. 2009;58:1-97.
2. Sin DD, Man SF. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14:115-21.
3. Stewart S. Prognosis of patients with heart failure compared with common types of cancer. Heart Fail Monit. 2003;3:87-94.
4. Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, et al. Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer. 2010;10:105.
5. Nelson CP, Lambert PC, Squire IB, Jones DR. Relative survival: what can cardiovascular disease learn from cancer? Eur Heart J. 2008;29:941-47.
6. Lai DJ, Tarwater PM, Hardy RJ. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000. Public Health. 2006;120:486-92.
7. Goldraich L, Beck-da-Silva L, Clausell N. Are scores useful in advanced heart failure? Expert Rev Cardiovasc Ther. 2009;7:985-97.
8. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, et al. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299:2533-42.
9. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5:167-73.
10. Sanders GD, Kong MH. Al Khatib SM, Peterson ED. Cost-effectiveness of implantable cardioverter defibrillators in patients > or = 65 years of age. Am Heart J. 2010;160:122-31.
11. You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. Am Heart J. 2007;154:899-907.
12. Jeldres C, Latouff JB, Saad F. Predicting life expectancy in prostate cancer patients. Curr Opin Support Palliat Care. 2009;3:166-69.
13. Parks SM, Winter L. End of life decision-making for cancer patients. Prim Care. 2009;36:811-23.
14. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med. 2008;11:84-103.
15. Jeldres C, Latouff JB, Saad F. Predicting life expectancy in prostate cancer patients. Curr Opin Support Palliat Care. 2009;3:166-69.
16. Kellett J. Prognostication-the lost skill of medicine. Eur J Intern Med. 2008;19:155-64.
17. Walz J, Gallina A, Hutterer G, Perrotte P, Shariat SF, Graefen M, et al. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;69:88-94.
18. Mazur DJ, Hickam DH. The effect of physician's explanations on patients' treatment preferences: five-year survival data. Med Decis Making. 1994;14:255-58.
19. Axente L, Sinescu C, Bazacliu G. Heart failure prognostic model. J Med Life. 2011;4:210-225.
20. Thomas JM, O'Leary JR, Fried TR. Understanding their options: determinants of hospice discussion for older persons with advanced illness. J Gen Intern Med. 2009;24:923-28.
21. Fried TR, Van Ness PH, Byers AL, Towle VR, O'Leary JR, Dubin JA. Changes in preferences for life-sustaining treatment among older persons with advanced illness. J Gen Intern Med. 2007;22:495-501.
22. Goldstein NE, Lynn J. Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med. 2006;49:10-18.
23. Kaufman SR. Making longevity in an aging society: linking ethical sensibility and Medicare spending. Med Anthropol. 2009;28:317-25.
24. Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qiu F, et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J. 2008;155:324-31.
25. Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302:2330- 2337.
26. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ. 1999;161:1257-61.
27. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441-46.
28. Bradshaw PJ, Ko DT, Newman AM, Donovan LR, Tu JV. Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart. 2006;92:905-9.
29. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-87.
30. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med. 1982;73:883-88.
31. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med. 1982;73:889-97.
32. Mark DB, Harrington RA, Lincoff AM, Califf RM, Nelson CL, Tsiatis AA, et al. Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes. Circulation. 2000;101:366-71.
33. Nelson CL, Sun JL, Tsiatis AA, Mark DB. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. Stat Med. 2008;27:5525-55.
34. Klein JP, Moeschberger ML. Survival Analysis: Techniques for censored and truncated data. New York, NY: Springer-Verlag; 1997.
35. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA. 2001;285:2101-8.
36. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49:2408-15.
37. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-15.
38. Mohan R, Beydoun HA, Beydoun MA, Barnes-Eley M, Davis J, Lance R et al. Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study. Qual Life Res. 2010.
39. Otten JD, Broeders MJ, Den Heeten GJ, Holland R, Fracheboud J, De Koning HJ, et al. Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program. Cancer. 2010;116:586-91.
40. Straatman H, Verbeek AL, Peer PG, Borm G. Estimating life expectancy and related probabilities in screen-detected breast cancer patients with restricted follow-up information. Stat Med. 2004;23:431-48.
41. Kao SC, Butow P, Bray V, Clarke SJ, Vardy J. Patient and oncologist estimates of survival in advanced cancer patients. Psychooncology. 2010.
42. Social Security Online Actuarial Publications. Social Security Online . 12-12-2010. Ref Type: Electronic Citation
43. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med. 2008;11:84-103.
44. Bain KT, Maxwell TL, Strassels SA, Whellan DJ. Hospice use among patients with heart failure. Am Heart J. 2009;158:118-25.
45. David AS, Mary R, Neil S, James G. Deaths from heart failure in general practice: implications for palliative care. Palliat Med. 2002;16:495-98.
46. Kelley AS, Morrison RS, Wenger NS, Ettner SL, Sarkisian CA. Determinants of treatment intensity for patients with serious illness: a new conceptual framework. J Palliat Med. 2010;13:807-13.
47. Lytsy P, Burell G, Westerling R. How do prescribing doctors anticipate the effect of statins? J Eval Clin Pract. 2010.
48. Stewart GC, Brooks K, Pratibhu PP, Tsang SW, Semigran MJ, Smith CM, et al. Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transplant. 2009;28:863-69.
49. Harbottle EJ, Birmingham CL, Sayani F. Anorexia nervosa: a survival analysis. Eat Weight Disord. 2008;13:e32-e34.
50. Hellstedt LF. Transitional care issues influencing access to health care: employability and insurability. Nurs Clin North Am. 2004;39:741-53.
51. Harper S, Lynch J, Burris S, Davey SG. Trends in the black-white life expectancy gap in the United States, 1983-2003. JAMA. 2007;297:1224-32.
52. Na'amnih W, Muhsen K, Tarabeia J, Saabneh A, Green MS. Trends in the gap in life expectancy between Arabs and Jews in Israel between 1975 and 2004. Int J Epidemiol. 2010;39:1324-32.
53. Weinstein MC. Economic assessments of medical practices and technologies. Med Decis Making. 1981;1:309-30.
54. Stone P, Kelly L, Head R, White S. Development and validation of a prognostic scale for use in patients with advanced cancer. Palliat Med. 2008;22:711-17.
55. Maltoni M, Amadori D. Prognosis in advanced cancer. Hematol Oncol Clin North Am. 2002;16:715-29.
56. Zanetti O, Solerte SB, Cantoni F. Life expectancy in Alzheimer's disease (AD). Arch Gerontol Geriatr. 2009;49(Suppl 1):237-43.